Johnson & Johnson
JNJ
$162.84
-$5.39-3.20%
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
P/E (TTM)
EPS (TTM)
| 10/02/2022 | 07/03/2022 | 04/03/2022 | 01/02/2022 | 10/03/2021 | |
|---|---|---|---|---|---|
| Revenue | 23.79B | 24.02B | 23.43B | 24.80B | 23.34B |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 23.79B | 24.02B | 23.43B | 24.80B | 23.34B |
| Cost of Revenue | 7.79B | 7.90B | 7.58B | 7.92B | 7.23B |
| Gross Profit | 16.00B | 16.12B | 15.84B | 16.88B | 16.11B |
| SG&A Expenses | 5.80B | 5.94B | 5.64B | 7.01B | 5.85B |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 17.19B | 17.54B | 16.68B | 19.65B | 16.50B |
| Operating Income | 6.60B | 6.48B | 6.74B | 5.16B | 6.84B |
| Income Before Tax | 5.82B | 5.84B | 5.86B | 4.84B | 3.85B |
| Income Tax Expenses | 1.36B | 1.03B | 713.00M | 100.00M | 182.00M |
| Earnings from Continuing Operations | 4.46B | 4.81B | 5.15B | 4.74B | 3.67B |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 4.46B | 4.81B | 5.15B | 4.74B | 3.67B |
| EBIT | 6.60B | 6.48B | 6.74B | 5.16B | 6.84B |
| EBITDA | 8.28B | 8.22B | 8.51B | 7.00B | 8.65B |
| EPS Basic | 1.70 | 1.83 | 1.96 | 1.80 | 1.39 |
| Normalized Basic EPS | 1.62 | 1.60 | 1.64 | 1.06 | 1.63 |
| EPS Diluted | 1.68 | 1.80 | 1.93 | 1.77 | 1.37 |
| Normalized Diluted EPS | 1.60 | 1.58 | 1.62 | 1.05 | 1.61 |
| Average Basic Shares Outstanding | 2.63B | 2.63B | 2.63B | 2.63B | 2.63B |
| Average Diluted Shares Outstanding | 2.66B | 2.67B | 2.67B | 2.67B | 2.67B |
| Dividend Per Share | 1.13 | 1.13 | 1.06 | 1.06 | 1.06 |
| Payout Ratio | 66.62% | 61.72% | 54.13% | 58.93% | 76.11% |
